CASI
NASDAQ
$0.21
CASI Pharmaceuticals Inc (CASI)
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and markets therapeutic and pharmaceutical products in China, the United States, and internationally. The company is headquartered in Rockville, Maryland.
Sector:
Healthcare
Industry:
Biotechnology
Target: $4 (+1827.71%)
Market Cap
$4.27M
Beta (5Y)
0.85
Price Chart
Valuation
Market Cap$4.27M
P/S0.12
P/B15.65
Profitability
Total Revenue (TTM)$21M
Gross Profit (TTM)$9.61M
EBITDA-$44M
Profit Margin-184%
Operating Margin-333.1%
EPS-$2.34
Financial Health
Debt-to-Equity-51.5%
Growth & Risk
EPS 5Y CAGR-11.77%
Revenue 5Y CAGR+6.66%
FCF 5Y CAGR-5.38%
Beta (5Y)0.85
Sharpe Ratio-0.76